Insights

Gathering insights about Arkuda Therapeutics…

Similar companies to Arkuda Therapeutics

Arkuda Therapeutics Tech Stack

Arkuda Therapeutics uses 8 technology products and services including jQuery CDN, MySQL, Google Cloud, and more. Explore Arkuda Therapeutics's tech stack below.

jQuery CDN
Content Delivery Network
MySQL
Database
Google Cloud
Infrastructure As A Service
TweenMax
Javascript Frameworks
GSAP
Javascript Frameworks
jQuery
Javascript Libraries
Open Graph
Miscellaneous
WP Engine
Platform As A Service

Media & News

Arkuda Therapeutics's Email Address Formats

Arkuda Therapeutics uses at least 1 format(s):

Arkuda Therapeutics Email Formats	Example	Percentage
FLast@arkudatx.com	JDoe@arkudatx.com	82%
First.Last@arkudatx.com	John.Doe@arkudatx.com	14%
Last@arkudatx.com	Doe@arkudatx.com	2%
FirstLast@arkudatx.com	JohnDoe@arkudatx.com	2%

Frequently Asked Questions

Where is Arkuda Therapeutics's headquarters located?

Arkuda Therapeutics's main headquarters is located at 200 Arsenal Yards Boulevard Suite 220 Watertown, Massachusetts 02472 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Arkuda Therapeutics's phone number?

You can contact Arkuda Therapeutics's main corporate office by phone at

+1-857-201-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arkuda Therapeutics's official website and social media links?

Arkuda Therapeutics's official website is arkudatx.com and has social profiles on LinkedIn.

How much revenue does Arkuda Therapeutics generate?

As of October 2024, Arkuda Therapeutics's annual revenue reached $1.8M.

What is Arkuda Therapeutics's SIC code NAICS code?

Arkuda Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arkuda Therapeutics have currently?

As of October 2024, Arkuda Therapeutics has approximately 17 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: G. K.Corporate Event Marketing Reporting To The Co-Founder, President & Ceo: D. D. J.Chairman, Board Of Directors: B. B.. Explore Arkuda Therapeutics's employee directory with LeadIQ.

What industry does Arkuda Therapeutics belong to?

Arkuda Therapeutics operates in the Biotechnology Research industry.

What technology does Arkuda Therapeutics use?

Arkuda Therapeutics's tech stack includes jQuery CDNMySQLGoogle CloudTweenMaxGSAPjQueryOpen GraphWP Engine.

What is Arkuda Therapeutics's email format?

Arkuda Therapeutics's email format typically follows the pattern of . Find more Arkuda Therapeutics email formats with LeadIQ.

How much funding has Arkuda Therapeutics raised to date?

As of October 2024, Arkuda Therapeutics has raised $64M in funding. The last funding round occurred on Feb 10, 2022 for $64M.

Arkuda Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.

Company Overview

Headquarters: 200 Arsenal Yards Boulevard Suite 220 Watertown, Massachusetts 02472 US
Phone number: ✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-857-201-****
Website: arkudatx.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Funding & Financials

$64M
Arkuda Therapeutics has raised a total of $64M of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2022 in the amount of $64M.
$10M
Arkuda Therapeutics's revenue is in the range of $10M

Funding & Financials

$64M
Arkuda Therapeutics has raised a total of $64M of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2022 in the amount of $64M.
$10M
Arkuda Therapeutics's revenue is in the range of $10M

Company Leadership

G. K.
Chief Executive Officer
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. D. J.
Corporate Event Marketing Reporting To The Co-Founder, President & Ceo
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. B.
Chairman, Board Of Directors
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Co-Founder And Chief Technology Officer
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. H.
Svp, Head Of Discovery
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. B.
Vice President, Neurobiology
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. E.
Vice President, Finance
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Vice President, Medicinal Chemistry
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. B.
Vice-President
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. R.
Director, Toxicology
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Arkuda Therapeutics and Millions of Other Companies
Sign up for full access to Arkuda Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Arkuda Therapeutics

ProThera Biologics

NGM Biopharmaceuticals

Arkuda Therapeutics Tech Stack

Media & News

Arkudatx promoted Raymond Hurst to Senior Vice President, Head of Discovery on Apr 4th '23.

Arkudatx hired Duane Burnett as Chief Technology Officer on Apr 4th '23.

Arkudatx is developing medicine for frontotemporal dementia on Feb 10th '22.

Arkudatx received financing of $64M in Series B on Feb 10th '22.

Arkudatx is developing small molecules that treat neurodegenerative diseases, including GRN-related frontotemporal dementia.

Pivotalbiovp invests into Arkudatx $64M.

Cormorant Asset Management invests into Arkudatx $64M.

Arkuda Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Arkuda Therapeutics's headquarters located?

What is Arkuda Therapeutics's phone number?

What is Arkuda Therapeutics's official website and social media links?

How much revenue does Arkuda Therapeutics generate?

What is Arkuda Therapeutics's SIC code NAICS code?

How many employees does Arkuda Therapeutics have currently?

What industry does Arkuda Therapeutics belong to?

What technology does Arkuda Therapeutics use?

What is Arkuda Therapeutics's email format?

How much funding has Arkuda Therapeutics raised to date?

Arkuda Therapeutics

Company Overview

Media & News

Arkudatx promoted Raymond Hurst to Senior Vice President, Head of Discovery on Apr 4th '23.

Arkudatx hired Duane Burnett as Chief Technology Officer on Apr 4th '23.

Arkudatx is developing medicine for frontotemporal dementia on Feb 10th '22.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?